Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer
Robert Siegel, MD
Published: Tuesday, Aug 22, 2017
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.
In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.
Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.
SELECTED LANGUAGE
Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.
In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.
Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.